Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS-Life Study
NCT03662711Phase 4Terminated
- Sponsor
- University of Ferrara
- Start
- Nov 2018
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Ferrara. Primary endpoint: Composite event of the first time to first re-hospitalization and/or death (all cause) at 12 months. Started Nov 2018; status: terminated.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03662711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662711.